Clinical Trials
15 trialsNCT06713837 2026-04-08
IMPACT-AML
Istituto Romagnolo per lo Studio dei Tumori Dino Amadori IRST S.r.l. IRCCS
Phase 3 Recruiting
NCT07289646 2026-01-14
Pegasus 2
University Hospital, Brest
Phase 3 Not yet recruiting
NCT01093196 2024-11-07
Lenalidomide and Dexamethasone Versus Melphalan Prednisone and Lenalidomide Versus Cyclophosphamide, Prednisone and Lenalidomide in Elderly Multiple Myeloma Patients
Fondazione EMN Italy Onlus
Phase 3 Completed
NCT02215980 2024-07-22
STUDY TO DETERMINE THE EFFICACY AND SAFETY OF STANDARD SCHEDULE VERSUS A NEW ALGORITHM OF DOSE REDUCTIONS IN ELDERLY AND UNFIT NEWLY DIAGNOSED MULTIPLE MYELOMA PATIENTS RECEIVING LENALIDOMIDE PLUS STEROIDS
Fondazione EMN Italy Onlus
Phase 3 Completed
NCT00171873 2020-03-26
Antiproliferative Effect of Octreotide in Patients With Metastasized Neuroendocrine Tumors of the Midgut
Philipps University Marburg
Phase 3 Completed
NCT03645018 2018-09-14
SOS2
Ospedale Santa Croce-Carle Cuneo
Phase 3 Completed
NCT00232934 2018-08-02
Melphalan, Prednisone and Thalidomide Versus Melphalan and Prednisone in Elderly Myeloma Patients
Gruppo Italiano per lo Studio del Mieloma Multiplo
Phase 3 Completed
NCT01659099 2018-03-07
GAINED
The Lymphoma Academic Research Organisation
Phase 3 Terminated
NCT00136890 2013-01-15
ELPET
Ontario Clinical Oncology Group (OCOG)
Phase 3 Completed
NCT00147472 2012-06-22
Positronic Emission Tomography (PET) Imaging in Post Radiation Evaluation of Head and Neck Tumours (PET PREVENT Trial)
Ontario Clinical Oncology Group (OCOG)
Phase 3 Completed
NCT00136864 2011-11-18
Positron Emission Tomography (PET) Imaging in Stage III Non-small Cell Lung Cancer (PET START Trial)
Ontario Clinical Oncology Group (OCOG)
Phase 3 Completed
NCT00851292 2011-06-22
BIOPRES
Amphia Hospital
Phase 3 Unknown
NCT00950768 2009-08-03
Melphalan 200 mg/m2 Versus Melphalan 100 mg/m2 in Newly Diagnosed Myeloma Patients
Azienda Ospedaliera San Giovanni Battista
Phase 3 Completed
NCT00201942 2007-10-18
PET Imaging to Determine the Role of PET in the Assessment of Regional Disease in Breast Cancer (PET PREDICT Trial)
Ontario Clinical Oncology Group (OCOG)
Phase 3 Completed
NCT00420862 2007-01-11
The DANTE Trial. A Randomized Study on Lung Cancer Screening With Low-Dose Spiral Computed Tomography
Istituto Clinico Humanitas
Phase 3 Terminated